Searched for
METHERGINE
Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...- Bayer's consumer health unit plans to step up India playIn an interview to ET, Sandeep Verma, country head, India, Bayer consumer health division in India, said the company will use its global ex...
- Dr Reddy's inks exclusive sales pact with Novartis IndiaUnder the arrangement, Dr Reddy's will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium rang...
- Novartis India enters distribution pact with DRL for top brands, to lay off 400 employeesNovartis India said its strategic business decision will lead to the separation of approximately 400 employees due to role redundancies.
- Replacing China as API supplier for pharma will be a medium to long term story: Lupin‘In the case of Lupin, the actual API import from China is on the lower side.’
- Buy Lupin, target Rs 1,030: HDFC SecuritiesBuy Lupin at a price target of Rs 1030.
- We expect domestic business to grow at 15%: S Ramesh, LupinI expect the price erosion to continue in America in the first two quarters at least for the current year before it stabilises around 8-10%.
- For Lupin, uncertainties of FY18 would continue in FY19: Ramesh Swaminathan“Biosimilars, complex generics and speciality would be key elements of Lupin strategy going forward”
- Lupin's US arm takes over Symbiomix TherapeuticsLupin had entered into an arrangement to acquire the company earlier this year.
- We now want to consolidate in Japan: S Ramesh, Lupin"We believe we should be position to launch at least between 25 to 30-35 products in the US market this year," said S Ramesh.
- Lupin looks to strengthen brand, specialty biz in the USThe company focuses on various therapeutic areas like paediatric, women's health, inhalation, derma and ophthalmology for that matter, he a...
- Lupin launches Methergine brand in US; drugmaker markets five brands in this marketLupin is bolstering its US branded drugs portfolio with the introduction of Methergine, an oral tablet used to treat postpartum haemorrhage...
Load More
